PMV Pharmaceuticals, Inc.

PMVP·NASDAQ·$1.23Share Price as of 11/2·$66MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/14/26 10-QQ1 ended 03/31/2605/12/26 10-KFY 202503/06/26 10-QQ3 ended 09/30/2511/12/25 10-QQ2 ended 06/30/2508/07/25

Disclosures

8-KCurrent report10/05/26 8-KCurrent report09/02/26 8-KCurrent report08/31/26 8-KCurrent report08/14/26 8-KCurrent report06/05/26

Prospectuses and Registrations

424B5Prospectus supplement09/02/26 424B3Prospectus08/31/26 424B5Prospectus supplement08/31/26 S-8Registration of securities for employees03/06/26 S-8Registration of securities for employees01/28/25

Proxies

DEF 14ADefinitive proxy04/22/26 DEFA14AAdditional proxy materials04/22/26 DEF 14ADefinitive proxy04/25/25 DEFA14AAdditional proxy materials04/25/25 DEF 14ADefinitive proxy04/24/24

Ownership

Form 3Initial insider ownership10/05/26 Form 4Insider transaction10/05/26 SC 13GBeneficial ownership09/15/26 SC 13G/ABeneficial ownership (amended)07/28/26 SC 13G/ABeneficial ownership (amended)07/10/26

Other

ARSAnnual report to shareholders04/22/26 ARSAnnual report to shareholders04/25/25 EFFECTRequest for effectiveness11/27/24 CORRESPCorrespondence with the SEC11/25/24 UPLOADLetter from the SEC11/25/24